Is There a Tirzepatide Pill? What Sellers Ship

No, there is no approved tirzepatide pill. Every FDA-approved tirzepatide product, Mounjaro and Zepbound, is an injection under the skin, and Lilly, the company that makes it, says directly that “tirzepatide is not available in pill form for oral administration.”^[1][2] What you can buy online is something else: compounded tirzepatide made into tablets, drops, lozenges and capsules by pharmacies. Of the sellers we review, 45 list one. None of these products has been reviewed by FDA, and no study has tested any of them in people.

No tirzepatide pill is FDA-approved

FDA has approved tirzepatide under two brand names. Mounjaro treats type 2 diabetes and Zepbound treats obesity and some related conditions. Both labels list one route: injection under the skin.^[2][3] We checked FDA’s approvals database and DailyMed, the National Library of Medicine’s label archive, on September 27, 2026. Every tirzepatide product listed there is an injectable solution. There is no tablet, capsule, film, spray or drop.

Lilly’s medical information team answers the question the same way: tirzepatide “is an injectable medicine for subcutaneous use.”^[1] Our tirzepatide drug page covers the approved products, doses and label warnings.

Why tirzepatide is hard to take by mouth

Lilly gives the reason in two sentences. The molecular weight of tirzepatide is 4,813.53 daltons, and “generally, medicines with a molecular weight greater than 500 daltons are not absorbed orally.”^[1] Tirzepatide is a peptide, a chain of amino acids, nearly ten times past that line. A 2026 lab study of an experimental tirzepatide tablet described the barriers: the drug crosses the gut wall poorly and dissolves differently depending on stomach acidity.^[5]

“Generally” matters. The Wegovy tablet proves a large peptide can be made into a pill, but it took a specific engineering fix. Its semaglutide is paired with salcaprozate sodium (SNAC), which the label calls “an absorption enhancer,” and its label sets strict conditions: a fasting morning dose with only a few ounces of plain water, no crushing, chewing or dissolving the tablet, and a half-hour wait before food or other pills.^[7] That is how narrow the conditions are for the one peptide pill that has been approved. Nobody has shown that a compounded tirzepatide tablet dissolved under the tongue gets around the same problem.

What sellers ship instead

Across the telehealth sellers we review, 45 list a non-injected compounded tirzepatide, and 44 of them list a price we can publish. We sorted each by how the seller itself describes the product. Each price is the lowest monthly price the seller lists for that product, using the same rules as its review page: a price you only get in the first month, or only by paying for several months at once, is labeled that way.

Across the 44 sellers with a publishable price, the lowest listed price runs from $119 to $419, and the middle seller asks $299 (3 of those figures are first-month or paid-up-front prices). For comparison, Lilly sells approved Zepbound to self-pay patients starting at $299 a month for the 2.5 mg dose, in a vial or KwikPen.^[11] 23 of the 44 priced oral products cost as much as that starting dose of the approved injection, or more.

Some products add a second drug. One seller’s dissolving tablet combines tirzepatide with ondansetron, a prescription anti-nausea medicine. A pharmacy survey of compounded GLP-1 products published in 2026 found this pattern was common: 48% of the 33 products it identified combined semaglutide or tirzepatide with another ingredient, and the single-ingredient products it found were sold as sublingual tablets (82%) or orally disintegrating tablets (18%).^[4]

If you are comparing sellers, our oral GLP-1 providers board and side-by-side table cover the same market with pharmacy and state details.

What has been tested: nothing, for these products

Every weight-loss number you have seen for tirzepatide comes from trials of the weekly injection. None of it transfers to a tablet dissolved under the tongue, because the dose that reaches your blood is the whole question, and nobody has measured it for these products in people.

• No human trial. ClinicalTrials.gov held 290 study records naming tirzepatide on September 27, 2026. None gives tirzepatide by mouth, under the tongue or as a tablet.^[10]
• Only animal and lab work. The closest published studies are a lab-made tirzepatide tablet with an absorption enhancer, tested in cells, rats and beagle dogs, and a milk-vesicle delivery method tested in diabetic mice.^[5][6] Neither is a product you can buy, and neither enrolled a person.
• No FDA review. FDA states that compounded drugs “are not FDA approved,” which “means the agency does not review compounded drugs for safety, effectiveness or quality before they are marketed.”^[9]

The pharmacists who surveyed these products put it plainly: there is a rationale for making sublingual or ODT versions, “but whether these formulations offer advantages over innovator oral tablets has not been determined.”^[4] Compounded injectable tirzepatide raises its own questions, covered in is compounded tirzepatide safe and what is in a compounded GLP-1 vial. An oral version adds one more unknown on top: how much of the drug you absorb.

The GLP-1 pills that are approved

Two once-daily pills are FDA-approved for weight loss. Both are different molecules from tirzepatide, and both come with a label, a manufacturer of record and trial data behind the dose.

Foundayo was first approved in 2026 and is indicated, alongside diet and activity, to reduce excess body weight in adults with obesity, or with overweight plus a weight-related condition.^[8] Our Foundayo explainer covers what its trials showed, and brand names versus molecules maps which name is which drug.

If you want tirzepatide, it is an injection

The approved way to take tirzepatide is a once-weekly shot under the skin. If the needle is the obstacle, the options are an approved pill with a different drug in it, or the injection with help from a prescriber on technique. Our tirzepatide providers board ranks sellers for brand and compounded injections, and the compounded tirzepatide board covers the compounded injectable market.